ScreenerHero

TRVN Trevena, Inc.

NAS · US · Healthcare · Biotechnology · trevena.com
0.0004USD0.00%Mkt Cap: 345 $P/E: —

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Olic…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap345 USD
Enterprise Value24.11M USD
Revenue (TTM)546.00K USD
Gross Profit1.46M USD
Net Income (TTM)-40.29M USD
Revenue/Share0.69 USD
Last Price0.0004 USD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.76
EV/Revenue44.16
P/S0.02
P/B-0.00
EPS (TTM)-52.75
EPS (Forward)-19.85
52W Range
0.00040% of range1.501
52W High1.501 USD
52W Low0.0004 USD
Profitability
Gross Margin46.56%
Oper. Margin-1970.67%
EBITDA Margin0.00%
Profit Margin-1289.25%
ROE526.17%
ROA-99.22%
Growth
Revenue Growth57.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-33.03M USD
CapEx (TTM)41.00K USD
FCF Margin-3081.27%
FCF Yield-4876449.28%
Net Debt24.10M USD
Net Debt/EBITDA-0.76
Balance Sheet
Debt/Equity-4.73
Current Ratio2.42
Quick Ratio2.21
Book Value/Sh-27.27 USD
Cash/Share15.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateAug 13, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.863.79K
Float859.07K
Insiders0.00%
Institutions11.00%
Short Interest
Short Ratio1.1d
Short % Float8.33%
Short % Out.8.25%
Shares Short70.48K
Short (prev mo.)20.07K
Technical
SMA 500.0049 (-91.8%)
SMA 2000.0091 (-95.6%)
Beta-1.95
S&P 52W Chg16.45%
Avg Vol (30d)67
Avg Vol (10d)289
Technical Indicators
RSI (14)20.7
MACD-0.0014
MACD Signal-0.0016
MACD Hist.+0.0002
BB Upper0.0014 USD
BB Middle0.0009 USD
BB Lower0.0004 USD
BB Width111.92%
ATR (14)0.0211 USD
Vol Ratio (20d)0.00x